| RB1 |
RB1: Retinoblastoma-associated protein |
DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
0.49 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
LAMA3 |
|
0.49 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
LAMA3 |
|
0.49 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
ADRA2A |
IPI00031712 |
0.49 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
HRH2 |
HRH2 protein |
0.49 |
Evidence |
|
| OPN1MW |
OPN1MW, GCP: Green-sensitive opsin |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.49 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
PAX5 |
PAX5: Paired box protein Pax-5 |
0.49 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
ACR |
ACR, ACRS: Acrosin precursor |
0.49 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
TSHR |
IPI00386365 |
0.49 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.49 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
TSHR |
IPI00386365 |
0.49 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
GPR88 |
GPR88, STRG: Probable G-protein coupled receptor 88 |
0.49 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
GPR17 |
IPI00012717 |
0.49 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
0.49 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
0.49 |
Evidence |
|
| MTA2 |
MTA1L1, MTA2, PID: Metastasis-associated protein MTA2 |
RB1 |
RB1: Retinoblastoma-associated protein |
0.49 |
Evidence |
|
| PPFIA3 |
PPFIA3, KIAA0654: Liprin-alpha-3 |
IRS1 |
IRS1: Insulin receptor substrate 1 |
0.49 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
OPN3 |
OPN3, ECPN: Opsin-3 |
0.49 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.49 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
0.49 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
TSHR |
IPI00386365 |
0.49 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.49 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
0.49 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.49 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
0.49 |
Evidence |
|